Celularity (CELU) Return on Equity [ROE] (2021 - 2025)
Celularity (CELU) reported Return on Equity [ROE] of -2489.82% for Q1 2025, down 2113.69 percentage points from -376.13% a year earlier and down 2196.08 percentage points from the prior quarter.
Powered by 
Analysis
Celularity (CELU) Return on Equity [ROE] (2021 - 2025) Analysis & Trends
For FY2024, Celularity posted Return on Equity [ROE] of -154.06%, up 6.27 percentage points from FY2023.
- By year, Return on Equity [ROE] came in at -160.33% in FY2023 (-143.17 pp) and -17.16% in FY2022.
- The Q1 2025 figure ranks as the lowest quarterly Return on Equity [ROE] in data going back to Q4 2021.
- Year over year, Return on Equity [ROE] gained in two of the last eight quarters, with an average year-over-year change of -386.42 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2024 (a gain of 246.34 percentage points); the low point was Q1 2025 (a drop of 2113.69 percentage points).
- Per Business Quant data, the three quarters before Q1 2025 came in at -293.74% (Q4 2024), -69.92% (Q3 2024) and -350.49% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.21 Bn | 1,108.80 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 632.33 Bn | 552.19 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 500.02 Bn | 473.13 Bn | 12.70 Bn | - |
| 4 | Merck | 355.31 Bn | 309.69 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 300.67 Bn | 264.66 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 263.56 Bn | 237.25 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.81 Bn | 193.20 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.42 Bn | 168.61 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn | 4.97% |
| 10 | Celularity | 29.79 Mn | 22.54 Mn | 3.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -2,489.82% |
| Dec 31, 2024 | -293.74% |
| Sep 30, 2024 | -69.92% |
| Jun 30, 2024 | -350.49% |
| Mar 31, 2024 | -376.13% |
| Dec 31, 2023 | -540.08% |
| Sep 30, 2023 | -252.93% |
| Jun 30, 2023 | -68.95% |
| Mar 31, 2023 | -27.00% |
| Dec 31, 2022 | -14.10% |
| Sep 30, 2022 | -36.92% |
| Jun 30, 2022 | -34.57% |
| Mar 31, 2022 | -112.27% |
| Dec 31, 2021 | -111.49% |
API Access
Celularity Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();